If You Invested in Tanke Biosciences Corp (TNBI)
Looking for the current price? See the TNBI quote & overviewWhat $1,000 or $10,000 in TNBI Would Be Worth Today
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Jan 3, 2022 |
|---|---|---|---|---|
| $1,000 | $448 -55% | — | — | $14 -99% |
| $10,000 | $4,478 -55% | — | — | $136 -99% |
Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for TNBI$1,000 Investment Over Time
TNBI vs S&P 500Year-by-Year Returns
TNBI annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2022 | $1.10 | $0.10 | -90.8% | -90.8% |
| 2023 | $0.10 | $0.15 | +48.4% | -86.4% |
| 2024 | $0.08 | $0.03 | -63.0% | -97.3% |
| 2025 | $0.02 | $0.03 | +27.1% | -97.6% |
| 2026 | $0.03 | $0.01 | -40.2% | -98.6% |
About Tanke Biosciences Corp
Financial Services · OTC Link
Tanke Biosciences Corp (TNBI) is described as an emerging diversified holding company. According to company statements, it focuses on identifying emerging, growth-stage businesses that have achieved some level of revenue traction, proof of concept, or customer and market adoption. The company’s goal is to provide these businesses with capital and management resources to help them scale profitable growth and build shareholder value through leadership in their respective market areas.
Business focus and model
Tanke Biosciences Corp positions itself as a holding company that seeks out businesses which have already demonstrated initial commercial validation. The company indicates that it targets enterprises that show evidence of revenue, working concepts, or early customer and market acceptance. By concentrating on this stage of development, Tanke Biosciences Corp aims to work with businesses that have moved beyond the idea phase and are ready to expand.
The company states that it intends to contribute both financial and managerial support to its portfolio businesses. This includes capital to fund growth as well as access to leadership experience in areas such as operations, finance, and strategic expansion. The emphasis on profitable growth suggests a focus on scaling organizations in a way that can sustain and enhance long-term value.
Management and leadership orientation
According to its public communications, Tanke Biosciences Corp highlights the experience of its management, advisors, and Board of Directors. The company notes that these individuals bring decades of leadership expertise in driving growth in organizations of various sizes. Their backgrounds include work in accounting, finance, operations, business turnarounds, and mergers and acquisitions, as well as experience in public company leadership and advisory roles.
The company’s leadership emphasizes building seasoned management, advisory, and operational teams. This focus aligns with its stated objective of partnering with businesses that are positioned to scale their existing models. By combining capital with operational and strategic guidance, Tanke Biosciences Corp aims to support portfolio companies as they pursue expansion in their market areas.
Geographic presence
Tanke Biosciences Corp reports that it is based in Delray Beach, Florida and Newark, New Jersey. These locations serve as the bases for its management, advisory, and board activities. The company’s communications reference experience working with organizations in different contexts, reflecting a background that spans various industries and business environments.
Sector and classification
Tanke Biosciences Corp is categorized in the Financial Services sector and associated with shell companies. Within this context, its stated strategy is to act as a diversified holding company, concentrating on emerging and growth-stage businesses that have already demonstrated some commercial traction. The company’s emphasis on capital injection, revenue growth and expansion, and operational excellence reflects a focus on value creation through active involvement in the development of its investments.
Growth and value orientation
In its own description, Tanke Biosciences Corp underscores a commitment to identifying businesses that are positioned to scale. The company highlights leadership expertise in areas such as strategic capital deployment, revenue expansion, and operational improvement. By aligning with businesses that have proof of concept or early market adoption, Tanke Biosciences Corp seeks to participate in the next phase of their growth while applying its management experience.
This approach is intended to support both the businesses in which it invests and the company’s shareholders. The focus on leadership in respective market areas indicates an interest in helping portfolio companies strengthen their competitive positions as they expand.
Organizational expertise
The company’s communications point to a background in driving strong growth in organizations of different sizes. This includes experience with business turnarounds, mergers and acquisitions, and building operational excellence. The leadership’s prior roles in public and private companies, advisory services, and academic involvement are cited as part of the expertise that Tanke Biosciences Corp aims to apply in its holding company activities.
Overall, Tanke Biosciences Corp presents itself as a holding company focused on emerging, growth-stage businesses, combining capital with management and advisory resources. Its stated objective is to help these businesses scale profitable growth and build shareholder value through leadership and operational strength in their chosen markets.
Similar Stocks
See how related companies performed
Frequently Asked Questions
Tanke Biosciences Corp investment returns
How much would $1,000 invested in Tanke Biosciences Corp be worth today?
If you invested $1,000 in Tanke Biosciences Corp (TNBI) 1 years ago on 2025-08-12, your investment would be worth $448 today, representing a -55.2% total return, growing at a compounded rate of -66.4% per year (CAGR).
Has Tanke Biosciences Corp outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare TNBI performance over available time periods.
What is Tanke Biosciences Corp's average annual return?
The compound annual growth rate (CAGR) of TNBI over the past 1 years is -66.4%, growing at a compounded rate each year. Individual years vary significantly — TNBI's best recent year was 2023 (+48.4%) and worst was 2022 (-90.8%).
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.
